Showing results (61-70 of 3,122) with videos related to
Sort By:
Pageof 313
Anti-Cancer Agents in Medicinal Chemistry|March 2, 2011
A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulonInes Batinic-Haberle, Zrinka Rajic, Ludmil BenovAnti-Cancer Agents in Medicinal Chemistry|March 2, 2011
The potential of Zn(II) N-alkylpyridylporphyrins for anticancer therapyLudmil Benov, James Craik, Ines Batinic-HaberleAnti-Cancer Agents in Medicinal Chemistry|April 29, 2011
Resveratrol and its analogues: promising antitumor agentsXianfeng Huang, Hai-Liang ZhuAnti-Cancer Agents in Medicinal Chemistry|June 10, 2011
Anti-cancer activity of nitrones and observations on mechanism of actionRobert A Floyd, Hema K Chandru, Ting He, et al.Anti-Cancer Agents in Medicinal Chemistry|November 3, 2011
Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?Tomoya YokotaAnti-Cancer Agents in Medicinal Chemistry|November 3, 2011
Cranberry as promising natural source of potential anticancer agents: current evidence and future perspectivesAthanasios Katsargyris, Ekaterini-Christina Tampaki, Constantinos Giaginis, et al.Anti-Cancer Agents in Medicinal Chemistry|November 3, 2011
Hepatocarcinogenesis and ceramide/cholesterol metabolismAlbert Morales, Montserrat Mari, Carmen Garcia-Ruiz, et al.Anti-Cancer Agents in Medicinal Chemistry|November 3, 2011
Molecular probing and imaging of histone deacetylase inhibitors in cancer treatmentHuang Jiaguo, Liu Zhiguo, Zeng WenbinAnti-Cancer Agents in Medicinal Chemistry|June 13, 2009
The intermediate enzymes of isoprenoid metabolism as anticancer targetsAndrew J Wiemer, Raymond J Hohl, David F WiemerAnti-Cancer Agents in Medicinal Chemistry|June 13, 2009
Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?J Thomas De Ligio, Aneliya Velkova, Diego A R Zorio, et al.Pageof 313